EFA Technologies

Infectious Disease Diagnostic System

Health Tech & Life Sciences
Active
Seed Yokne'am Illit Founded 2016
Total raised
$9.5M
Last: Debt Financing 2024-04
Stage
Seed
Founded
2016
Headcount
17
HQ
Yokne'am Illit
Sector
Health Tech & Life Sciences

About

EFA Technologies is developing the RevDx, an affordable handheld blood test diagnostic tool. The RevDx is a mobile end-point solution for performing automatic microscopy tests, including whole blood sampling and an automatic diagnosis of blood count. The product is easy to operate and uses a blood sample from finger prick without the need for laboratory conditions or specific preparations, enabling users to make real-time informed decisions. The RevDx is a disease-mapping solution for integrated community case management. The real-time, multichannel platform is a programmable portable lab that aims to automatically diagnose infectious diseases, starting with parasitology and blood cell count, in order to enable safe, precise, and affordable testing, treating, and tracking.

Funding history · 5 rounds · $9.5M total

2024-04
Debt Financing $6.5M
2022-01
SAFE $1.0M
2022-01
Convertible Debt $3.6M
2020-09
Seed Undisclosed
2018-12
Seed Undisclosed

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics DevicesDigital HealthcareDigital Medical Diagnostics
Technologies
SensingPlatforms & InterfacesSoftwareArtificial IntelligenceMachine Learning
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2BB2B2CB2G

Highlights

1 PatentsVerified

Tags

digital-healthcareblood-testmhealthtelemedicineinfectious-diseasediagnosticsmedical-devicessensorsclinicsimage-processingdeep-learningsoftware-applicationsdata-analyticsmachine-learningartificial-intelligencedoctorshome-care